Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study.
Jelena ČelutkienėKamilė Čerlinskaitė-BajorėGad CotterChristopher EdwardsMarianna AdamoMattia ArrigoMarianela BarrosJan BiegusOvidiu ChioncelAlain Cohen-SolalAlbertino DamascenoRafael DiazGerasimos FilippatosEtienne GayatAntoine KimmounValentine LéopoldBenjamin DeniauMarco MetraMaria NovosadovaMatteo PagnesiPeter S PangPiotr PonikowskiHadiza SaiduKaren SliwaKoji TakagiJozine M Ter MaatenDaniela TomasoniCarolyn S P LamAdriaan A VoorsAlexandre MebazaaBeth DavisonPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2024)
Hemoglobin level and status of anemia have a dynamic nature in the acute HF patients in the post-discharge period dependent on multiple factors. High-intensity HF treatment is safe and beneficial regardless of baseline hemoglobin level and presence of anemia. The improvement of quality of life is significantly lower in anemic HF patients implying specific attention to correction of this condition.